142 related articles for article (PubMed ID: 37451663)
1. Ginsenosides in cancer: Targeting cell cycle arrest and apoptosis.
Shah MA; Abuzar SM; Ilyas K; Qadees I; Bilal M; Yousaf R; Kassim RMT; Rasul A; Saleem U; Alves MS; Khan H; Blundell R; Jeandet P
Chem Biol Interact; 2023 Sep; 382():110634. PubMed ID: 37451663
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg5 induces G2/M phase arrest, apoptosis and autophagy via regulating ROS-mediated MAPK pathways against human gastric cancer.
Liu Y; Fan D
Biochem Pharmacol; 2019 Oct; 168():285-304. PubMed ID: 31301277
[TBL] [Abstract][Full Text] [Related]
3. Preparation and bioactivity of the rare ginsenosides Rg3 and Rh2: An updated review.
Xu W; Lyu W; Duan C; Ma F; Li X; Li D
Fitoterapia; 2023 Jun; 167():105514. PubMed ID: 37084851
[TBL] [Abstract][Full Text] [Related]
4. 20(S)-ginsenoside Rh2 inhibits the proliferation and induces the apoptosis of KG-1a cells through the Wnt/β-catenin signaling pathway.
Chen Y; Liu ZH; Xia J; Li XP; Li KQ; Xiong W; Li J; Chen DL
Oncol Rep; 2016 Jul; 36(1):137-46. PubMed ID: 27121661
[TBL] [Abstract][Full Text] [Related]
5. Targeted antitumor activity of Ginsenoside (Rg1) in paclitaxel-resistant human nasopharyngeal cancer cells are mediated through activation of autophagic cell death, cell apoptosis, endogenous ROS production, S phase cell cycle arrest and inhibition of m-TOR/PI3K/AKT signalling pathway.
Li W; Li G; She W; Hu X; Wu X
J BUON; 2019; 24(5):2056-2061. PubMed ID: 31786875
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-β expression.
Chung KS; Cho SH; Shin JS; Kim DH; Choi JH; Choi SY; Rhee YK; Hong HD; Lee KT
Carcinogenesis; 2013 Feb; 34(2):331-40. PubMed ID: 23125221
[TBL] [Abstract][Full Text] [Related]
7. Induction of G2/M phase cell cycle arrest and apoptosis by ginsenoside Rf in human osteosarcoma MG‑63 cells through the mitochondrial pathway.
Shangguan WJ; Li H; Zhang YH
Oncol Rep; 2014 Jan; 31(1):305-13. PubMed ID: 24173574
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53.
Li B; Zhao J; Wang CZ; Searle J; He TC; Yuan CS; Du W
Cancer Lett; 2011 Feb; 301(2):185-92. PubMed ID: 21194832
[TBL] [Abstract][Full Text] [Related]
9. 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway.
Zhang F; Li M; Wu X; Hu Y; Cao Y; Wang X; Xiang S; Li H; Jiang L; Tan Z; Lu W; Weng H; Shu Y; Gong W; Wang X; Zhang Y; Shi W; Dong P; Gu J; Liu Y
Drug Des Devel Ther; 2015; 9():3969-87. PubMed ID: 26309394
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective Effects of Ginsenosides against Cerebral Ischemia.
Cheng Z; Zhang M; Ling C; Zhu Y; Ren H; Hong C; Qin J; Liu T; Wang J
Molecules; 2019 Mar; 24(6):. PubMed ID: 30897756
[TBL] [Abstract][Full Text] [Related]
11. The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice.
Zhu H; He YS; Ma J; Zhou J; Kong M; Wu CY; Mao Q; Lin G; Li SL
J Ethnopharmacol; 2021 Jan; 265():113271. PubMed ID: 32853742
[TBL] [Abstract][Full Text] [Related]
12. Efficient thermal deglycosylation of ginsenoside Rd and its contribution to the improved anticancer activity of ginseng.
Kim YJ; Yamabe N; Choi P; Lee JW; Ham J; Kang KS
J Agric Food Chem; 2013 Sep; 61(38):9185-91. PubMed ID: 23984628
[TBL] [Abstract][Full Text] [Related]
13. Anticancer property of ginsenoside Rh2 from ginseng.
Li X; Chu S; Lin M; Gao Y; Liu Y; Yang S; Zhou X; Zhang Y; Hu Y; Wang H; Chen N
Eur J Med Chem; 2020 Oct; 203():112627. PubMed ID: 32702586
[TBL] [Abstract][Full Text] [Related]
14. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.
Tang XP; Tang GD; Fang CY; Liang ZH; Zhang LY
World J Gastroenterol; 2013 Mar; 19(10):1582-92. PubMed ID: 23538603
[TBL] [Abstract][Full Text] [Related]
15. [Ginsenoside Rh2 inhibits proliferation and promotes apoptosis of leukemia KG1-α cells].
You Z; Chen D; Wei Q; Zhao L; Xia J; Li D; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):565-8. PubMed ID: 24909273
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.
Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL
Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938
[TBL] [Abstract][Full Text] [Related]
17. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
[TBL] [Abstract][Full Text] [Related]
18. Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach.
Zarneshan SN; Fakhri S; Khan H
Pharmacol Res; 2022 Mar; 177():106099. PubMed ID: 35092819
[TBL] [Abstract][Full Text] [Related]
19. Anticancer Effects of Ginsenoside Rh2: A Systematic Review.
He XL; Xu XH; Shi JJ; Huang M; Wang Y; Chen X; Lu JJ
Curr Mol Pharmacol; 2022; 15(1):179-189. PubMed ID: 33687905
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of Ginsenosides (Rb
Zheng F; Zhang MY; Wu YX; Wang YZ; Li FT; Han MX; Dai YL; Yue H
Chem Biodivers; 2021 Dec; 18(12):e2100296. PubMed ID: 34665516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
